Her-2: The Making of Herceptin, a Revolutionary Treatment for Breast Cancer

Valutazione media 3,95
( su 104 valutazioni fornite da Goodreads )
 
9780812991840: Her-2: The Making of Herceptin, a Revolutionary Treatment for Breast Cancer

Two years after she underwent a mastectomy and chemotherapy, Barbara Bradfield's aggressive breast cancer had recurred and spread to her lungs. The outlook was grim. Then she took part in Genentech's clinical trials for a new drug. Five years later she remains cancer-free.

        Her-2 is the biography of Herceptin, the drug that provoked dramatic responses in Barbara Bradfield and other women in the trials and that offers promise for hundreds of thousands of breast cancer patients. Unlike chemotherapy or radiation, Herceptin has no disabling side effects. It works by inactivating Her-2/neu--a protein that makes cancer cells grow especially quickly-- produced by a gene found in 25 to 30 percent of all breast tumors. Herceptin caused some patients' cancers to disappear completely; in others, it slowed the progression of the disease and gave the women months or years they wouldn't otherwise have had. Herceptin is the first treatment targeted at a gene defect that gives rise to cancer. It marks the beginning of a new era of treatment for all kinds of cancers.

        Robert Bazell presents a riveting account of how Herceptin was born. Her-2 is a story of dramatic discoveries and strong personalities, showing the combination of scientific investigation, money, politics, ego, corporate decisions, patient activism, and luck involved in moving this groundbreaking drug from the lab to a patient's bedside. Bazell's deft portraits introduce us to the remarkable people instrumental in Herceptin's history, including Dr. Dennis Slamon, the driven UCLA oncologist who played the primary role in developing the treatment; Lily Tartikoff, wife of television executive Brandon Tartikoff, who tapped into Hollywood money and glamour to help fund Slamon's research; and Marti Nelson, who inspired the activists who lobbied for a "compassionate use" program that would allow women outside the clinical trials to have access to the limited supplies of Herceptin prior to FDA approval of the drug. And throughout there are the stories of the heroic women with advanced breast cancer who volunteered for the trials, risking what time they had left on an unproven treatment. Meticulously researched, written with clarity and compassion, Her-2 is masterly reporting on cutting-edge science.
From the Hardcover edition.

Le informazioni nella sezione "Riassunto" possono far riferimento a edizioni diverse di questo titolo.

Review:

Her-2: The Making of Herceptin, a Revolutionary Treatment for Breast Cancer reads like a novel at first. Oncologist Dennis Slamon has spent 13 years "obsessed with a molecule called Her-2," which he believed "held the key to nothing less than curing breast cancer." The book chronicles the search to unlock the secrets of Her-2/neu, a protein that makes cancer cells grow quickly; the discovery of the Her-2/neu antibody, which resulted in tumors shrinking and, sometimes, remission of the cancer; and the development of the drug Herceptin. It is also the story of the women with breast cancer who participated in Herceptin's clinical trials, including Anne McNamara, who has been fighting tumor after tumor since 1978.

The scientific and research-history sections are heavy and slow going, but Robert Bazell effectively juxtaposes the difficult scientific concepts and long research history of Her-2 with human drama. He keeps bringing the reader back to the threads of the personal stories we are following--especially the women with breast cancer and their determination to recapture their health. This is what makes Her-2 so compelling. --Joan Price

From the Back Cover:

"A fascinating description of the people and politics behind the development of a new breast cancer treatment. With Her-2 we are finally seeing the fulfillment of research's promise to move us behind slash, burn, and poison toward a more targeted approach to this devastating disease."--Susan Love, M.D., author of Dr. Susan Love's Breast Book

Le informazioni nella sezione "Su questo libro" possono far riferimento a edizioni diverse di questo titolo.

I migliori risultati di ricerca su AbeBooks

1.

Bazell, Robert
Editore: Random House Inc (1998)
ISBN 10: 0812991842 ISBN 13: 9780812991840
Nuovi Quantità: > 20
Da
Paperbackshop-US
(Wood Dale, IL, U.S.A.)
Valutazione libreria
[?]

Descrizione libro Random House Inc, 1998. PAP. Condizione libro: New. New Book. Shipped from US within 10 to 14 business days. Established seller since 2000. Codice libro della libreria VR-9780812991840

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 6,76
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 3,40
In U.S.A.
Destinazione, tempi e costi

2.

Robert Bazell
ISBN 10: 0812991842 ISBN 13: 9780812991840
Nuovi Quantità: > 20
Da
BWB
(Valley Stream, NY, U.S.A.)
Valutazione libreria
[?]

Descrizione libro Condizione libro: New. Depending on your location, this item may ship from the US or UK. Codice libro della libreria 97808129918400000000

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 10,22
Convertire valuta

Aggiungere al carrello

Spese di spedizione: GRATIS
In U.S.A.
Destinazione, tempi e costi

3.

BAZELL, ROBERT
Editore: Penguin Random House
ISBN 10: 0812991842 ISBN 13: 9780812991840
Nuovi Quantità: > 20
Da
INDOO
(Avenel, NJ, U.S.A.)
Valutazione libreria
[?]

Descrizione libro Penguin Random House. Condizione libro: New. Brand New. Codice libro della libreria 0812991842

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 7,66
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 2,98
In U.S.A.
Destinazione, tempi e costi

4.

Bazell, Robert
Editore: Random House Inc (1998)
ISBN 10: 0812991842 ISBN 13: 9780812991840
Nuovi Quantità: 3
Da
Pbshop
(Wood Dale, IL, U.S.A.)
Valutazione libreria
[?]

Descrizione libro Random House Inc, 1998. PAP. Condizione libro: New. New Book.Shipped from US within 10 to 14 business days. Established seller since 2000. Codice libro della libreria IB-9780812991840

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 8,04
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 3,40
In U.S.A.
Destinazione, tempi e costi

5.

Robert Bazell
Editore: Random House USA Inc, United States (1998)
ISBN 10: 0812991842 ISBN 13: 9780812991840
Nuovi Paperback Quantità: 1
Da
The Book Depository
(London, Regno Unito)
Valutazione libreria
[?]

Descrizione libro Random House USA Inc, United States, 1998. Paperback. Condizione libro: New. Language: English . Brand New Book. Two years after she underwent a mastectomy and chemotherapy, Barbara Bradfield s aggressive breast cancer had recurred and spread to her lungs. The outlook was grim. Then she took part in Genentech s clinical trials for a new drug. Five years later she remains cancer-free. Her-2 is the biography of Herceptin, the drug that provoked dramatic responses in Barbara Bradfield and other women in the trials and that offers promise for hundreds of thousands of breast cancer patients. Unlike chemotherapy or radiation, Herceptin has no disabling side effects. It works by inactivating Her-2/neu--a protein that makes cancer cells grow especially quickly-- produced by a gene found in 25 to 30 percent of all breast tumors. Herceptin caused some patients cancers to disappear completely; in others, it slowed the progression of the disease and gave the women months or years they wouldn t otherwise have had. Herceptin is the first treatment targeted at a gene defect that gives rise to cancer. It marks the beginning of a new era of treatment for all kinds of cancers. Robert Bazell presents a riveting account of how Herceptin was born. Her-2 is a story of dramatic discoveries and strong personalities, showing the combination of scientific investigation, money, politics, ego, corporate decisions, patient activism, and luck involved in moving this groundbreaking drug from the lab to a patient s bedside. Bazell s deft portraits introduce us to the remarkable people instrumental in Herceptin s history, including Dr. Dennis Slamon, the driven UCLA oncologist who played the primary role in developing the treatment; Lily Tartikoff, wife of television executive Brandon Tartikoff, who tapped into Hollywood money and glamour to help fund Slamon s research; and Marti Nelson, who inspired the activists who lobbied for a compassionate use program that would allow women outside the clinical trials to have access to the limited supplies of Herceptin prior to FDA approval of the drug. And throughout there are the stories of the heroic women with advanced breast cancer who volunteered for the trials, risking what time they had left on an unproven treatment. Meticulously researched, written with clarity and compassion, Her-2 is masterly reporting on cutting-edge science. From the Hardcover edition. Codice libro della libreria AAC9780812991840

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 11,84
Convertire valuta

Aggiungere al carrello

Spese di spedizione: GRATIS
Da: Regno Unito a: U.S.A.
Destinazione, tempi e costi

6.

Robert Bazell
Editore: Random House USA Inc, United States (1998)
ISBN 10: 0812991842 ISBN 13: 9780812991840
Nuovi Paperback Quantità: 1
Da
The Book Depository US
(London, Regno Unito)
Valutazione libreria
[?]

Descrizione libro Random House USA Inc, United States, 1998. Paperback. Condizione libro: New. Language: English . Brand New Book. Two years after she underwent a mastectomy and chemotherapy, Barbara Bradfield s aggressive breast cancer had recurred and spread to her lungs. The outlook was grim. Then she took part in Genentech s clinical trials for a new drug. Five years later she remains cancer-free. Her-2 is the biography of Herceptin, the drug that provoked dramatic responses in Barbara Bradfield and other women in the trials and that offers promise for hundreds of thousands of breast cancer patients. Unlike chemotherapy or radiation, Herceptin has no disabling side effects. It works by inactivating Her-2/neu--a protein that makes cancer cells grow especially quickly-- produced by a gene found in 25 to 30 percent of all breast tumors. Herceptin caused some patients cancers to disappear completely; in others, it slowed the progression of the disease and gave the women months or years they wouldn t otherwise have had. Herceptin is the first treatment targeted at a gene defect that gives rise to cancer. It marks the beginning of a new era of treatment for all kinds of cancers. Robert Bazell presents a riveting account of how Herceptin was born. Her-2 is a story of dramatic discoveries and strong personalities, showing the combination of scientific investigation, money, politics, ego, corporate decisions, patient activism, and luck involved in moving this groundbreaking drug from the lab to a patient s bedside. Bazell s deft portraits introduce us to the remarkable people instrumental in Herceptin s history, including Dr. Dennis Slamon, the driven UCLA oncologist who played the primary role in developing the treatment; Lily Tartikoff, wife of television executive Brandon Tartikoff, who tapped into Hollywood money and glamour to help fund Slamon s research; and Marti Nelson, who inspired the activists who lobbied for a compassionate use program that would allow women outside the clinical trials to have access to the limited supplies of Herceptin prior to FDA approval of the drug. And throughout there are the stories of the heroic women with advanced breast cancer who volunteered for the trials, risking what time they had left on an unproven treatment. Meticulously researched, written with clarity and compassion, Her-2 is masterly reporting on cutting-edge science. From the Hardcover edition. Codice libro della libreria AAC9780812991840

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 11,87
Convertire valuta

Aggiungere al carrello

Spese di spedizione: GRATIS
Da: Regno Unito a: U.S.A.
Destinazione, tempi e costi

7.

Robert Bazell
Editore: Random House USA Inc, United States (1998)
ISBN 10: 0812991842 ISBN 13: 9780812991840
Nuovi Paperback Quantità: 10
Da
Book Depository hard to find
(London, Regno Unito)
Valutazione libreria
[?]

Descrizione libro Random House USA Inc, United States, 1998. Paperback. Condizione libro: New. Language: English . This book usually ship within 10-15 business days and we will endeavor to dispatch orders quicker than this where possible. Brand New Book. Two years after she underwent a mastectomy and chemotherapy, Barbara Bradfield s aggressive breast cancer had recurred and spread to her lungs. The outlook was grim. Then she took part in Genentech s clinical trials for a new drug. Five years later she remains cancer-free. Her-2 is the biography of Herceptin, the drug that provoked dramatic responses in Barbara Bradfield and other women in the trials and that offers promise for hundreds of thousands of breast cancer patients. Unlike chemotherapy or radiation, Herceptin has no disabling side effects. It works by inactivating Her-2/neu--a protein that makes cancer cells grow especially quickly-- produced by a gene found in 25 to 30 percent of all breast tumors. Herceptin caused some patients cancers to disappear completely; in others, it slowed the progression of the disease and gave the women months or years they wouldn t otherwise have had. Herceptin is the first treatment targeted at a gene defect that gives rise to cancer. It marks the beginning of a new era of treatment for all kinds of cancers. Robert Bazell presents a riveting account of how Herceptin was born. Her-2 is a story of dramatic discoveries and strong personalities, showing the combination of scientific investigation, money, politics, ego, corporate decisions, patient activism, and luck involved in moving this groundbreaking drug from the lab to a patient s bedside. Bazell s deft portraits introduce us to the remarkable people instrumental in Herceptin s history, including Dr. Dennis Slamon, the driven UCLA oncologist who played the primary role in developing the treatment; Lily Tartikoff, wife of television executive Brandon Tartikoff, who tapped into Hollywood money and glamour to help fund Slamon s research; and Marti Nelson, who inspired the activists who lobbied for a compassionate use program that would allow women outside the clinical trials to have access to the limited supplies of Herceptin prior to FDA approval of the drug. And throughout there are the stories of the heroic women with advanced breast cancer who volunteered for the trials, risking what time they had left on an unproven treatment. Meticulously researched, written with clarity and compassion, Her-2 is masterly reporting on cutting-edge science. From the Hardcover edition. Codice libro della libreria BTE9780812991840

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 11,96
Convertire valuta

Aggiungere al carrello

Spese di spedizione: GRATIS
Da: Regno Unito a: U.S.A.
Destinazione, tempi e costi

8.

Bazell, Robert
Editore: Random House (1998)
ISBN 10: 0812991842 ISBN 13: 9780812991840
Nuovi Paperback Quantità: 1
Da
Murray Media
(North Miami Beach, FL, U.S.A.)
Valutazione libreria
[?]

Descrizione libro Random House, 1998. Paperback. Condizione libro: New. Codice libro della libreria 0812991842

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 11,64
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 2,55
In U.S.A.
Destinazione, tempi e costi

9.

Bazell, Robert
Editore: Random House
ISBN 10: 0812991842 ISBN 13: 9780812991840
Nuovi PAPERBACK Quantità: > 20
Da
Mediaoutlet12345
(Springfield, VA, U.S.A.)
Valutazione libreria
[?]

Descrizione libro Random House. PAPERBACK. Condizione libro: New. 0812991842 *BRAND NEW* Ships Same Day or Next!. Codice libro della libreria SWATI2132246423

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 12,58
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 3,40
In U.S.A.
Destinazione, tempi e costi

10.

Robert Bazell
Editore: Random House (1998)
ISBN 10: 0812991842 ISBN 13: 9780812991840
Nuovi Paperback Quantità: 1
Da
Ergodebooks
(RICHMOND, TX, U.S.A.)
Valutazione libreria
[?]

Descrizione libro Random House, 1998. Paperback. Condizione libro: New. 1. Codice libro della libreria DADAX0812991842

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 12,93
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 3,40
In U.S.A.
Destinazione, tempi e costi

Vedi altre copie di questo libro

Vedi tutti i risultati per questo libro